| 2D Structure | |
| CID | 15899899 |
| IUPAC Name | sodium (4-aminophenyl)sulfonyl-(4-methylpyrimidin-2-yl)azanide |
| InChI | InChI=1S/C11H11N4O2S.Na/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10;/h2-7H,12H2,1H3;/q-1;+1 |
| InChI Key | BSFJGCCAXDCMOX-UHFFFAOYSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C11H11N4NaO2S |
| Molecular Weight | 286.29 |
| synonyms | ['SULFAMERAZINE SODIUM', '127-58-2', 'Soluble sulfamerazine', 'Sulfamerazin natrium', 'Sodium sulphamerazine', 'Sulfamerazine sodique', 'Solfamerazina sodica', 'Sulfamerazina sodica', 'Sulfamerazine sodium [INN]', 'Solfamerazina sodica [DCIT]', 'Sulfamerazinum natricum', '2-Sulfanilamido-4-methylpyrimidine sodium salt', 'UNII-JOV4UJY07O', 'JOV4UJY07O', 'Sulfamerazina sodica [INN-Spanish]', 'Sulfamerazine sodique [INN-French]', 'EINECS 204-851-0', 'Sulfamerazinum natricum [INN-Latin]', 'Monosodium 2-sulfanilamido-4-methylpyrimidine', '4-Methyl-2-sulfanilamidopyrimidine sodium salt', 'Sulfamerazine Sodium Injection', 'NSC 226823', 'SULFAMERAZINE SODIUM [INJECTION]', 'Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-, monosodium salt', 'Sulfamerazine sodium [Injection] [INN:NF]', 'N(sup 1)-(4-Methyl-2-pyrimidinyl)sulfanilamide sodium salt', 'Sodium derivate of N1-(4-methyl-2-pyrimidinyl)sulfanilamide', 'DTXSID1051644', 'SULFAMERAZINE SODIUM [MART.]', 'SULFAMERAZINE SODIUM [WHO-DD]', 'Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)-, monosodium salt', 'Sulfanilamide, N(sup 1)-(4-methyl-2-pyrimidinyl)-, monosodium salt', 'Sulfamerazina sodica (INN-Spanish)', 'Sulfamerazine sodique (INN-French)', 'Sulfamerazinum natricum (INN-Latin)', 'SULFAMERAZINE SODIUM (MART.)', 'SULFAMERAZINE SODIUM (INJECTION)', 'RefChem:186493', 'DTXCID2030196', 'Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)-, monosodium salt (8CI)', 'Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-, monosodium salt (9CI)', '204-851-0', 'Sulfamerazine sodium salt', 'Sodium sulfamerazine', 'Solumedine', 'Sulfamerazine (sodium salt)', 'Sulfamerazine monosodium salt', 'sodium;(4-aminophenyl)sulfonyl-(4-methylpyrimidin-2-yl)azanide', 'NSC-226823', 'sodium;4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide', 'Sulfamerazinnatrium', 'Sulfamerazina de sodio', 'SULFAMERAZINESODIUM', 'SCHEMBL2820643', 'CHEMBL2107260', 'HY-B0512A', 'BSFJGCCAXDCMOX-UHFFFAOYSA-N', 'CHEBI:201395', 'sodium,(4-aminophenyl)sulfonyl-(4-methylpyrimidin-2-yl)azanide', 'AKOS015913915', 'AT25528', 'SULFAMERAZINE MONOSODIUM SALT [MI]', 'DB-041864', 'NS00041928', 'SR-01000883950', 'SR-01000883950-1', 'Q27281612', 'Sodium ((4-aminophenyl)sulfonyl)(4-methylpyrimidin-2-yl)amide', 'sodium;(4-aminophenyl)sulonyl-(4-methylpyrimidin-2-yl)azanide', 'Sodium (4-aminobenzene-1-sulfonyl)(4-methylpyrimidin-2-yl)azanide'] |
From Pubchem